Artificial Organs Market ? Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Organ Type (Artificial Heart, Artificial Kidney, Artificial Pancreas, Artificial Lungs, Others), By Type (Mechanical, Biomechanical, Biological), By Material Type (Inanimate Polymers, Combination of Inanimate Polymers & Living Cells, Only Living Cells), By Region & Competition, 2021-2031F
The Global Artificial Organs Market is projected to expand from USD 30.55 Billion in 2025 to USD 54.15 Billion by 2031, reflecting a CAGR of 10.01%. These engineered devices are essential for mimicking the physiological duties of failing natural organs like the heart, liver, or kidneys. Key factors fueling this market include a critical worldwide scarcity of donor organs and a growing prevalence of chronic illnesses that lead to end-stage organ failure. Furthermore, aging global populations are experiencing higher rates of organ degeneration, increasing the need for mechanical solutions to sustain life when biological transplants are not an option.
However, the industry faces substantial hurdles due to stringent regulatory processes and exorbitant development costs that slow down market entry. These obstacles limit how quickly innovative devices can become available to patients. The pressing need for these technologies is highlighted by the continuing gap between the supply of donors and patient demand. According to the Organ Procurement and Transplantation Network, over 100,000 candidates were on the national transplant waiting list in the United States in 2024, demonstrating the vital gap artificial technologies must fill to mitigate the shortage of biological alternatives.
Market Driver
The primary force behind the Global Artificial Organs Market is the acute shortage of human donor organs combined with lengthening transplant waiting lists. As the incidence of chronic conditions like cardiac and renal failure rises, the gap between the limited availability of biological organs and the massive demand continues to grow. This disparity necessitates engineered alternatives acting as either destination therapies or bridges to transplantation. The severity of supply constraints is underscored by data from the Health Resources and Services Administration in January 2025, which noted that the U.S. healthcare system performed only 27,759 kidney transplants in 2024?a number insufficient to meet the needs of the large patient population requiring renal replacement, forcing clinicians to rely on mechanical support systems to prevent mortality.
Simultaneously, rapid progress in 3D bioprinting and biocompatible materials is accelerating market expansion by improving device safety and function. Innovations utilizing titanium, bio-printed scaffolds, and magnetic levitation are successfully lowering rejection rates and enhancing durability. A major breakthrough was reported by The Texas Heart Institute in July 2024, announcing the first-in-human implantation of the BiVACOR Total Artificial Heart during an FDA early feasibility study. Such technological strides are translating into commercial success; for example, Carmat reported in January 2025 that annual sales for its Aeson artificial heart reached ?7 million in 2024, a 2.5-fold increase over the prior year, marking a transition from experimental prototypes to viable commercial solutions.
Market Challenge
High capital requirements and rigorous regulatory frameworks stand as significant barriers to the growth of the Global Artificial Organs Market. The development of these life-sustaining devices necessitates intricate engineering and extensive safety testing, resulting in prolonged timelines that discourage investment and delay commercial release. The substantial financial cost of clinical trials and regulatory reviews creates a "valley of death," causing many promising technologies to fail due to a lack of funding before generating revenue. Consequently, companies are often forced to set premium prices for their products, which restricts adoption and accessibility within cost-conscious healthcare systems.
These delays are notably apparent in the lag between regulatory clearance and actual reimbursement, which essentially defines market entry. According to the Advanced Medical Technology Association (AdvaMed), the median wait time for a Medicare coverage decision on a new FDA-cleared medical technology was approximately 5.7 years in 2024. This extended period of uncertainty prevents manufacturers from reaching patients quickly, as the lack of insurance coverage makes these expensive therapies unaffordable for most users, ultimately hindering market growth and slowing innovation cycles.
Market Trends
The renal care landscape is being transformed by the rise of portable and wearable artificial kidney devices, which address the mobility constraints of traditional hemodialysis. This trend emphasizes the creation of lightweight, compact systems that enable continuous blood purification while allowing patients to maintain active lifestyles, thereby vastly enhancing their quality of life. Moving beyond stationary clinical infrastructure, these innovations offer patient-centric, home-based solutions that replicate the natural kidney's continuous filtration. For instance, Medindia reported in November 2024 that AWAK Technologies began a pre-pivotal clinical trial for a wearable peritoneal dialysis device weighing just 3 kilograms, aiming to provide patients with greater freedom from clinic-based treatments.
Concurrently, the incorporation of the Internet of Things (IoT) and artificial intelligence for real-time device monitoring is revolutionizing the management and optimization of artificial organ systems. Industry leaders are utilizing advanced algorithms to predict complications, remotely monitor patient health markers, and personalize treatment plans, reducing the strain on healthcare facilities. This digital shift ensures mechanical support systems can dynamically adapt to physiological changes, improving device longevity and patient safety. Highlighting this trend, Fresenius Medical Care announced in November 2024 that its AI-powered Anemia Control Model was selected for the Centers for Medicare & Medicaid Services AI Demo Days, demonstrating the increasing dependence on intelligent software to enhance renal replacement therapies.
Key Market Players
In this report, the Global Artificial Organs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Artificial Organs Market.
Available Customizations:
Global Artificial Organs Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
However, the industry faces substantial hurdles due to stringent regulatory processes and exorbitant development costs that slow down market entry. These obstacles limit how quickly innovative devices can become available to patients. The pressing need for these technologies is highlighted by the continuing gap between the supply of donors and patient demand. According to the Organ Procurement and Transplantation Network, over 100,000 candidates were on the national transplant waiting list in the United States in 2024, demonstrating the vital gap artificial technologies must fill to mitigate the shortage of biological alternatives.
Market Driver
The primary force behind the Global Artificial Organs Market is the acute shortage of human donor organs combined with lengthening transplant waiting lists. As the incidence of chronic conditions like cardiac and renal failure rises, the gap between the limited availability of biological organs and the massive demand continues to grow. This disparity necessitates engineered alternatives acting as either destination therapies or bridges to transplantation. The severity of supply constraints is underscored by data from the Health Resources and Services Administration in January 2025, which noted that the U.S. healthcare system performed only 27,759 kidney transplants in 2024?a number insufficient to meet the needs of the large patient population requiring renal replacement, forcing clinicians to rely on mechanical support systems to prevent mortality.
Simultaneously, rapid progress in 3D bioprinting and biocompatible materials is accelerating market expansion by improving device safety and function. Innovations utilizing titanium, bio-printed scaffolds, and magnetic levitation are successfully lowering rejection rates and enhancing durability. A major breakthrough was reported by The Texas Heart Institute in July 2024, announcing the first-in-human implantation of the BiVACOR Total Artificial Heart during an FDA early feasibility study. Such technological strides are translating into commercial success; for example, Carmat reported in January 2025 that annual sales for its Aeson artificial heart reached ?7 million in 2024, a 2.5-fold increase over the prior year, marking a transition from experimental prototypes to viable commercial solutions.
Market Challenge
High capital requirements and rigorous regulatory frameworks stand as significant barriers to the growth of the Global Artificial Organs Market. The development of these life-sustaining devices necessitates intricate engineering and extensive safety testing, resulting in prolonged timelines that discourage investment and delay commercial release. The substantial financial cost of clinical trials and regulatory reviews creates a "valley of death," causing many promising technologies to fail due to a lack of funding before generating revenue. Consequently, companies are often forced to set premium prices for their products, which restricts adoption and accessibility within cost-conscious healthcare systems.
These delays are notably apparent in the lag between regulatory clearance and actual reimbursement, which essentially defines market entry. According to the Advanced Medical Technology Association (AdvaMed), the median wait time for a Medicare coverage decision on a new FDA-cleared medical technology was approximately 5.7 years in 2024. This extended period of uncertainty prevents manufacturers from reaching patients quickly, as the lack of insurance coverage makes these expensive therapies unaffordable for most users, ultimately hindering market growth and slowing innovation cycles.
Market Trends
The renal care landscape is being transformed by the rise of portable and wearable artificial kidney devices, which address the mobility constraints of traditional hemodialysis. This trend emphasizes the creation of lightweight, compact systems that enable continuous blood purification while allowing patients to maintain active lifestyles, thereby vastly enhancing their quality of life. Moving beyond stationary clinical infrastructure, these innovations offer patient-centric, home-based solutions that replicate the natural kidney's continuous filtration. For instance, Medindia reported in November 2024 that AWAK Technologies began a pre-pivotal clinical trial for a wearable peritoneal dialysis device weighing just 3 kilograms, aiming to provide patients with greater freedom from clinic-based treatments.
Concurrently, the incorporation of the Internet of Things (IoT) and artificial intelligence for real-time device monitoring is revolutionizing the management and optimization of artificial organ systems. Industry leaders are utilizing advanced algorithms to predict complications, remotely monitor patient health markers, and personalize treatment plans, reducing the strain on healthcare facilities. This digital shift ensures mechanical support systems can dynamically adapt to physiological changes, improving device longevity and patient safety. Highlighting this trend, Fresenius Medical Care announced in November 2024 that its AI-powered Anemia Control Model was selected for the Centers for Medicare & Medicaid Services AI Demo Days, demonstrating the increasing dependence on intelligent software to enhance renal replacement therapies.
Key Market Players
- SynCardia
- Carmat
- Abbott
- Medtronic
- Fresenius Medical Care
- NxStage
- Terumo
- Boston Scientific
- APL
- Nipro
In this report, the Global Artificial Organs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Artificial Organs Market, By Organ Type
- Artificial Heart
- Artificial Kidney
- Artificial Pancreas
- Artificial Lungs
- Others
- Artificial Organs Market, By Type
- Mechanical
- Biomechanical
- Biological
- Artificial Organs Market, By Material Type
- Inanimate Polymers
- Combination of Inanimate Polymers & Living Cells
- Only Living Cells
- Artificial Organs Market, By Region
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Artificial Organs Market.
Available Customizations:
Global Artificial Organs Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL ARTIFICIAL ORGANS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Organ Type (Artificial Heart, Artificial Kidney, Artificial Pancreas, Artificial Lungs, Others)
5.2.2. By Type (Mechanical, Biomechanical, Biological)
5.2.3. By Material Type (Inanimate Polymers, Combination of Inanimate Polymers & Living Cells, Only Living Cells)
5.2.4. By Region
5.2.5. By Company (2025)
5.3. Market Map
6. NORTH AMERICA ARTIFICIAL ORGANS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Organ Type
6.2.2. By Type
6.2.3. By Material Type
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Artificial Organs Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Organ Type
6.3.1.2.2. By Type
6.3.1.2.3. By Material Type
6.3.2. Canada Artificial Organs Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Organ Type
6.3.2.2.2. By Type
6.3.2.2.3. By Material Type
6.3.3. Mexico Artificial Organs Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Organ Type
6.3.3.2.2. By Type
6.3.3.2.3. By Material Type
7. EUROPE ARTIFICIAL ORGANS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Organ Type
7.2.2. By Type
7.2.3. By Material Type
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Artificial Organs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Organ Type
7.3.1.2.2. By Type
7.3.1.2.3. By Material Type
7.3.2. France Artificial Organs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Organ Type
7.3.2.2.2. By Type
7.3.2.2.3. By Material Type
7.3.3. United Kingdom Artificial Organs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Organ Type
7.3.3.2.2. By Type
7.3.3.2.3. By Material Type
7.3.4. Italy Artificial Organs Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Organ Type
7.3.4.2.2. By Type
7.3.4.2.3. By Material Type
7.3.5. Spain Artificial Organs Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Organ Type
7.3.5.2.2. By Type
7.3.5.2.3. By Material Type
8. ASIA PACIFIC ARTIFICIAL ORGANS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Organ Type
8.2.2. By Type
8.2.3. By Material Type
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Artificial Organs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Organ Type
8.3.1.2.2. By Type
8.3.1.2.3. By Material Type
8.3.2. India Artificial Organs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Organ Type
8.3.2.2.2. By Type
8.3.2.2.3. By Material Type
8.3.3. Japan Artificial Organs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Organ Type
8.3.3.2.2. By Type
8.3.3.2.3. By Material Type
8.3.4. South Korea Artificial Organs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Organ Type
8.3.4.2.2. By Type
8.3.4.2.3. By Material Type
8.3.5. Australia Artificial Organs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Organ Type
8.3.5.2.2. By Type
8.3.5.2.3. By Material Type
9. MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Organ Type
9.2.2. By Type
9.2.3. By Material Type
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Artificial Organs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Organ Type
9.3.1.2.2. By Type
9.3.1.2.3. By Material Type
9.3.2. UAE Artificial Organs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Organ Type
9.3.2.2.2. By Type
9.3.2.2.3. By Material Type
9.3.3. South Africa Artificial Organs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Organ Type
9.3.3.2.2. By Type
9.3.3.2.3. By Material Type
10. SOUTH AMERICA ARTIFICIAL ORGANS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Organ Type
10.2.2. By Type
10.2.3. By Material Type
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Artificial Organs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Organ Type
10.3.1.2.2. By Type
10.3.1.2.3. By Material Type
10.3.2. Colombia Artificial Organs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Organ Type
10.3.2.2.2. By Type
10.3.2.2.3. By Material Type
10.3.3. Argentina Artificial Organs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Organ Type
10.3.3.2.2. By Type
10.3.3.2.3. By Material Type
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL ARTIFICIAL ORGANS MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. SynCardia
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Carmat
15.3. Abbott
15.4. Medtronic
15.5. Fresenius Medical Care
15.6. NxStage
15.7. Terumo
15.8. Boston Scientific
15.9. APL
15.10. Nipro
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL ARTIFICIAL ORGANS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Organ Type (Artificial Heart, Artificial Kidney, Artificial Pancreas, Artificial Lungs, Others)
5.2.2. By Type (Mechanical, Biomechanical, Biological)
5.2.3. By Material Type (Inanimate Polymers, Combination of Inanimate Polymers & Living Cells, Only Living Cells)
5.2.4. By Region
5.2.5. By Company (2025)
5.3. Market Map
6. NORTH AMERICA ARTIFICIAL ORGANS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Organ Type
6.2.2. By Type
6.2.3. By Material Type
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Artificial Organs Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Organ Type
6.3.1.2.2. By Type
6.3.1.2.3. By Material Type
6.3.2. Canada Artificial Organs Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Organ Type
6.3.2.2.2. By Type
6.3.2.2.3. By Material Type
6.3.3. Mexico Artificial Organs Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Organ Type
6.3.3.2.2. By Type
6.3.3.2.3. By Material Type
7. EUROPE ARTIFICIAL ORGANS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Organ Type
7.2.2. By Type
7.2.3. By Material Type
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Artificial Organs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Organ Type
7.3.1.2.2. By Type
7.3.1.2.3. By Material Type
7.3.2. France Artificial Organs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Organ Type
7.3.2.2.2. By Type
7.3.2.2.3. By Material Type
7.3.3. United Kingdom Artificial Organs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Organ Type
7.3.3.2.2. By Type
7.3.3.2.3. By Material Type
7.3.4. Italy Artificial Organs Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Organ Type
7.3.4.2.2. By Type
7.3.4.2.3. By Material Type
7.3.5. Spain Artificial Organs Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Organ Type
7.3.5.2.2. By Type
7.3.5.2.3. By Material Type
8. ASIA PACIFIC ARTIFICIAL ORGANS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Organ Type
8.2.2. By Type
8.2.3. By Material Type
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Artificial Organs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Organ Type
8.3.1.2.2. By Type
8.3.1.2.3. By Material Type
8.3.2. India Artificial Organs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Organ Type
8.3.2.2.2. By Type
8.3.2.2.3. By Material Type
8.3.3. Japan Artificial Organs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Organ Type
8.3.3.2.2. By Type
8.3.3.2.3. By Material Type
8.3.4. South Korea Artificial Organs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Organ Type
8.3.4.2.2. By Type
8.3.4.2.3. By Material Type
8.3.5. Australia Artificial Organs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Organ Type
8.3.5.2.2. By Type
8.3.5.2.3. By Material Type
9. MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Organ Type
9.2.2. By Type
9.2.3. By Material Type
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Artificial Organs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Organ Type
9.3.1.2.2. By Type
9.3.1.2.3. By Material Type
9.3.2. UAE Artificial Organs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Organ Type
9.3.2.2.2. By Type
9.3.2.2.3. By Material Type
9.3.3. South Africa Artificial Organs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Organ Type
9.3.3.2.2. By Type
9.3.3.2.3. By Material Type
10. SOUTH AMERICA ARTIFICIAL ORGANS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Organ Type
10.2.2. By Type
10.2.3. By Material Type
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Artificial Organs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Organ Type
10.3.1.2.2. By Type
10.3.1.2.3. By Material Type
10.3.2. Colombia Artificial Organs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Organ Type
10.3.2.2.2. By Type
10.3.2.2.3. By Material Type
10.3.3. Argentina Artificial Organs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Organ Type
10.3.3.2.2. By Type
10.3.3.2.3. By Material Type
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL ARTIFICIAL ORGANS MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. SynCardia
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Carmat
15.3. Abbott
15.4. Medtronic
15.5. Fresenius Medical Care
15.6. NxStage
15.7. Terumo
15.8. Boston Scientific
15.9. APL
15.10. Nipro
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
